How to Improve TRUS-Guided Target Biopsy following Prostate MRI

TRUS is a basic imaging modality when radiologists or urologists perform cognitive fusion or image fusion biopsy. This modality plays the role of the background images to add to an operator’s cognitive function or MRI images. Operators need to know how to make TRUS protocols for lesion detection or...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Byung Kwan Park
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/967856d02324463a92ef6a0f84a757a1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:967856d02324463a92ef6a0f84a757a1
record_format dspace
spelling oai:doaj.org-article:967856d02324463a92ef6a0f84a757a12021-11-25T17:02:01ZHow to Improve TRUS-Guided Target Biopsy following Prostate MRI10.3390/cancers132256472072-6694https://doaj.org/article/967856d02324463a92ef6a0f84a757a12021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5647https://doaj.org/toc/2072-6694TRUS is a basic imaging modality when radiologists or urologists perform cognitive fusion or image fusion biopsy. This modality plays the role of the background images to add to an operator’s cognitive function or MRI images. Operators need to know how to make TRUS protocols for lesion detection or targeting. Tumor location, size, and shape on TRUS are different from those on MRI because the scan axis is different. TRUS findings of peripheral or transition tumors are not well known to radiologists and urologists. Moreover, it remains unclear if systematic biopsy is necessary after a tumor is targeted. The purpose of this review is to introduce new TRUS protocols, new imaging features, new biopsy techniques, and to assess the necessity of systematic biopsy for improving biopsy outcomes.Byung Kwan ParkMDPI AGarticleprostate cancertransrectal ultrasoundbiopsymagnetic resonance imagingNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5647, p 5647 (2021)
institution DOAJ
collection DOAJ
language EN
topic prostate cancer
transrectal ultrasound
biopsy
magnetic resonance imaging
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle prostate cancer
transrectal ultrasound
biopsy
magnetic resonance imaging
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Byung Kwan Park
How to Improve TRUS-Guided Target Biopsy following Prostate MRI
description TRUS is a basic imaging modality when radiologists or urologists perform cognitive fusion or image fusion biopsy. This modality plays the role of the background images to add to an operator’s cognitive function or MRI images. Operators need to know how to make TRUS protocols for lesion detection or targeting. Tumor location, size, and shape on TRUS are different from those on MRI because the scan axis is different. TRUS findings of peripheral or transition tumors are not well known to radiologists and urologists. Moreover, it remains unclear if systematic biopsy is necessary after a tumor is targeted. The purpose of this review is to introduce new TRUS protocols, new imaging features, new biopsy techniques, and to assess the necessity of systematic biopsy for improving biopsy outcomes.
format article
author Byung Kwan Park
author_facet Byung Kwan Park
author_sort Byung Kwan Park
title How to Improve TRUS-Guided Target Biopsy following Prostate MRI
title_short How to Improve TRUS-Guided Target Biopsy following Prostate MRI
title_full How to Improve TRUS-Guided Target Biopsy following Prostate MRI
title_fullStr How to Improve TRUS-Guided Target Biopsy following Prostate MRI
title_full_unstemmed How to Improve TRUS-Guided Target Biopsy following Prostate MRI
title_sort how to improve trus-guided target biopsy following prostate mri
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/967856d02324463a92ef6a0f84a757a1
work_keys_str_mv AT byungkwanpark howtoimprovetrusguidedtargetbiopsyfollowingprostatemri
_version_ 1718412790748676096